Mesabi Shs (MSB) Gets a Buy Rating from Dawson James

Dawson James analyst Jason Kolbert maintained a Buy rating on Mesabi Shs (MSBResearch Report) on November 15 and set a price target of $20.00. The company’s shares closed last Tuesday at $28.67.

According to TipRanks.com, Kolbert has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -7.6% and a 35.5% success rate. Kolbert covers the Healthcare sector, focusing on stocks such as Brainstorm Cell Therapeutics, Citius Pharmaceuticals, and Sorrento Therapeutics.

Mesabi Shs has an analyst consensus of Moderate Buy, with a price target consensus of $20.00.

See the top stocks recommended by analysts >>

Mesabi Shs’ market cap is currently $376.2M and has a P/E ratio of 6.13.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Mesabi Trust engages in the collection of and distribution of royalties and payment of expenses and liabilities. It holds interest in Peter Mitchell iron mine located near Babbitt and in Silver Bay, Minnesota. The company was founded on July 18, 1961 and is headquartered in New York, NY.

Read More on MSB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed